| Autor: |
Caruso P; Hospital A C Camargo, ICU and Respiratory ICU, Pulmonary Division, University of Sao Paulo Medical School, São Paulo, Brazil. pedro.caruso@hcnet.usp.br, Ferreira AC, Laurienzo CE, Titton LN, Terabe DS, Carnieli DS, Deheinzelin D |
| Jazyk: |
angličtina |
| Zdroj: |
European journal of cancer care [Eur J Cancer Care (Engl)] 2010 Mar; Vol. 19 (2), pp. 260-6. Date of Electronic Publication: 2009 Aug 26. |
| DOI: |
10.1111/j.1365-2354.2008.01031.x |
| Abstrakt: |
Decisions for intensive care unit (ICU) admissions in patients with advanced cancer are complex, and the knowledge of survival rates and prognostic factors are essential to these decisions. Ours objectives were to describe the short- and long-term survival of patients with metastatic solid cancer admitted to an ICU due to emergencies and to study the prognostic factors presented at ICU admission that could be associated with hospital mortality. We retrospectively analysed the charts of all patients with metastatic solid cancer admitted over a 1-year period. This gave a study sample of 83 patients. The ICU, hospital, 1-year and 2-year survival rates were 55.4%, 28.9%, 12.0% and 2.4% respectively. Thrombocytopenia (odds ratio 26.2; P = 0.006) and simplified acute physiology score (SAPS II) (odds ratio 1.09; P = 0.026) were independent factors associated with higher hospital mortality. In conclusion, the survival rates of patients with metastatic solid cancer admitted to the ICU due to emergencies were low, but of the same magnitude as other groups of cancer patients admitted to the ICU. The SAPS II score and thrombocytopenia on admission were associated with higher hospital mortality. The characteristics of the metastatic disease, such as number of organs with metastasis and central nervous system metastasis were not associated with the hospital mortality. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
